New Novartis PREVENT data show Cosentyx® delivers early relief in axial spondyloarthritis

NASDAQ Market News

NEXT STORY
Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment
PREV STORY
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in electroCore, Inc. of Class Action Lawsuit and Upcoming Deadline – ECOR
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA Grants T2 Biosystems Breakthrough Device Designation for the T2Resistance™ Panel; Expected Availability through CE Mark in 2019

author_avatar
NASDAQ Market News

The global LFIA based rapid test market was valued at $4,725 million in 2018, and is projected to reach $8,494 million by 2026, registering a CAGR of 7.6% from 2019 to 2026

author_avatar
NASDAQ Market News

Aptose Announces Proposed Public Offering of Common Shares

author_avatar
NASDAQ Market News